Form 4: Integra LifeSciences Executive Harvinder Singh Reports Stock Transactions

EVP & President, International, Harvinder Singh, reports the vesting of restricted stock units and adjustments to previously reported holdings in Integra LifeSciences.

Summary

• On March 10, 2024, Harvinder Singh, EVP & President, International at Integra LifeSciences, reported transactions involving the company's stock.
• Singh acquired 1,179 shares of common stock through the vesting of restricted stock units (RSUs).
• The vesting price was $0.
• Following the transaction, Singh directly owns 1,179 shares of common stock.
• Singh also reported owning 14,361 derivative securities (Restricted Stock Units).
• An adjustment was made to correct a minor error on a previously filed Form 4, resulting in a decrease of 95 RSUs previously over-reported.
• The restricted stock unit award vests in three tranches: 33% on the first and second anniversaries, and 34% on the third anniversary of the grant date of March 10, 2023.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment. It reports routine stock transactions by an executive, with a minor correction to a previous filing. The vesting of RSUs is generally a positive sign, but the document itself is simply a factual report.

Positives

• The vesting of RSUs indicates that performance milestones have been met, which can be seen as a positive sign.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• Equity compensation, such as RSUs, is a common tool used by companies like Integra LifeSciences to align the interests of executives with those of shareholders, similar to practices at companies like Medtronic or Stryker.

Stakeholder Impact

• The reported transactions provide transparency to shareholders regarding executive compensation and ownership.

Key Dates